Lineage Cell Therapeutics Balance Sheet (2010-2026) | LCTX

Frequency:

Period:

1Y 3Y 5Y 7Y 10Y All

Values in:

Download Data

Balance Sheet	Jun2021	Sep2021	Dec2021	Mar2022	Jun2022	Sep2022	Dec2022	Mar2023	Jun2023	Sep2023	Dec2023	Mar2024	Jun2024	Sep2024	Dec2024	Mar2025	Jun2025	Sep2025	Dec2025	Mar2026
Assets
Current Assets
Cash & Equivalents (Quarter)	62.00M	60.81M	55.74M	78.06M	70.86M	24.75M	11.36M	15.45M	33.89M	31.47M	35.44M	43.58M	29.62M	27.75M	41.02M	47.89M	35.68M	32.22M	45.97M	45.27M
Short-term Investments (Quarter)	6.75M	4.29M	2.62M	1.88M	1.17M	41.60M	46.52M	31.36M	12.04M	9.86M	0.05M	0.04M	8.87M	4.96M	2.02M	0.02M	0.02M	0.02M	14.99M	17.44M
Cash & Current Investments (Quarter)	68.75M	65.10M	58.36M	79.94M	72.03M	66.36M	57.88M	46.81M	45.92M	41.33M	35.49M	43.62M	38.50M	32.71M	43.03M	47.91M	35.69M	32.24M	60.95M	62.72M
Receivables - Net (Quarter)	0.33M	2.12M	50.64M	0.52M	0.53M	0.43M	0.30M	0.17M	0.44M	0.43M	0.70M	0.08M	0.23M	0.41M	0.64M	0.21M	0.26M	0.13M	0.89M	0.81M
Receivables - Other (Quarter)			0.54M		0.20M	0.55M	0.58M											0.55M	0.67M	0.58M
Receivables (Quarter)	0.33M	2.12M	51.17M	0.52M	0.73M	0.98M	0.88M	0.17M	0.44M	0.43M	0.70M	0.08M	0.23M	0.41M	0.64M	0.21M	0.26M	0.68M	1.56M	1.39M
Inventory (Quarter)
Current Deferred Tax Assets (Quarter)
Prepaid Assets (Quarter)	2.50M	3.16M	2.35M	1.41M	1.29M	1.72M	1.83M	2.64M	2.12M	1.72M	2.20M	2.02M	1.66M	1.28M	2.55M	1.87M	1.30M	1.65M	2.48M	1.98M
Current Assets (Quarter)	71.58M	68.34M	111.55M	81.87M	74.03M	68.51M	60.00M	49.66M	48.49M	43.48M	38.44M	45.72M	40.39M	34.40M	51.00M	49.98M	43.84M	42.26M	59.16M	56.16M
Non-Current Assets
Construction in Progress (Quarter)
Property, Plant & Equipment (Net) (Quarter)	5.01M	4.73M	4.87M	4.55M	3.87M	4.65M	5.67M	5.58M	5.31M	4.85M	2.25M	2.10M	2.02M	2.01M	2.25M	2.15M	2.25M	2.16M	2.57M	2.50M
Long-Term Investments (Quarter)
Goodwill (Quarter)	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M	10.67M
Intangibles (Quarter)	46.89M	46.50M	46.82M	46.50M	46.76M	46.50M	66.14M	46.50M	46.50M	66.14M	46.54M	46.54M	66.14M	66.14M			31.70M		31.70M	31.70M
Goodwill & Intangibles (Quarter)	57.56M	57.17M	57.49M	57.17M	57.43M	57.17M	76.81M	57.17M	57.17M	76.81M	57.21M	57.21M	76.81M	76.81M	10.67M	10.67M	42.37M	10.67M	42.37M	42.37M
Long-Term Deferred Tax (Quarter)															0.27M				5.80M	5.80M
Other Non-Current Assets (Quarter)	0.61M	0.61M	0.63M	0.64M	0.50M	0.59M	0.63M	0.64M	0.59M	0.55M	0.58M	0.60M	0.60M	0.61M	0.61M	0.50M	0.51M	0.54M	0.56M	0.57M
Non-Current Assets (Quarter)	63.18M	62.87M	4.87M	62.65M	61.90M	62.64M	5.67M	63.55M	63.20M	62.67M	62.58M	62.77M	62.41M	62.19M	62.22M	61.77M	46.95M	47.38M	53.43M	53.37M
Assets (Quarter)	134.75M	131.21M	174.54M	144.52M	135.92M	131.15M	123.66M	113.20M	111.69M	106.15M	101.02M	108.48M	102.80M	96.59M	113.22M	111.75M	90.80M	89.64M	112.58M	109.53M
Liabilities
Current Liabilities
Accounts Payables (Quarter)	2.72M	6.71M	3.54M	2.96M	8.68M	9.81M	8.61M	3.00M	4.68M	2.43M	6.27M	5.68M	2.39M	1.60M	5.44M	4.98M	1.50M	1.52M	7.18M	1.59M
Notes Payables (Quarter)
Payables (Quarter)	2.72M	6.71M	3.54M	2.96M	8.68M	9.81M	8.61M	3.00M	4.68M	2.43M	6.27M	5.68M	2.39M	1.60M	5.44M	4.98M	1.50M	1.52M	7.18M	1.59M
Accumulated Expenses (Quarter)	0.80M	1.64M	2.16M	21.00M	1.59M	1.91M	2.38M	0.40M	0.58M	0.35M	3.12M	0.99M	2.22M	2.49M	1.20M	2.08M	2.16M	2.54M	1.10M	1.23M
Other Accumulated Expenses (Quarter)	0.49M	0.07M	0.18M	0.08M	0.01M	0.03M		0.04M	0.00M
Short term Debt (Quarter)
Current Leases (Quarter)	0.02M	0.80M	0.80M	0.03M	0.03M	0.54M	0.92M	0.05M	0.05M	0.88M	0.05M	0.05M	0.05M	1.08M	0.06M	1.12M	1.00M	0.04M	0.04M	0.83M
Current Deferred Revenue (Quarter)	0.61M	0.89M	18.12M	14.88M	41.50M	38.91M	9.42M	11.01M	32.10M	9.91M	10.81M	10.11M	9.14M	8.25M	7.39M	6.93M	5.26M	3.77M	3.33M	1.72M
Total Current Liabilities (Quarter)	6.77M	8.79M	47.12M	24.59M	25.09M	22.74M	18.98M	17.23M	16.05M	15.88M	17.96M	16.89M	15.28M	13.86M	13.98M	13.09M	10.76M	9.38M	11.37M	8.15M
Non-Current Liabilities
Capital Leases (Quarter)	0.02M	0.01M	0.03M	0.03M	0.02M	0.02M	0.08M	0.13M	0.11M	0.10M	0.09M	0.08M	0.07M	0.08M	0.07M	0.05M	0.05M	0.04M	0.03M	0.02M
Non-Current Debt (Quarter)
Convertible Debt (Quarter)
Non-Current Deffered Revenue (Quarter)			32.45M	30.82M	25.77M	26.54M	27.73M	24.02M	21.69M	21.20M	18.69M	18.18M	18.54M	16.05M	14.43M	13.61M	12.75M	12.46M	12.38M	13.00M
Minority Interest (Quarter)	-1.11M	-1.12M	-1.32M	-1.33M	-1.35M	-1.40M	-1.40M	-1.44M	-1.41M	-1.46M	-1.40M	-1.41M	-1.43M	-1.39M	-1.37M	-1.37M	-1.27M	-1.24M	-1.20M	-1.18M
Non-Current Deferred Tax Liability (Quarter)	1.91M	0.89M	2.08M	2.08M	2.08M	2.08M	2.08M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.27M	0.02M	0.02M
Operating Leases (Quarter)	2.08M	1.89M	1.94M	1.78M	2.05M	2.22M	2.86M	2.54M	2.30M	2.05M	1.98M	2.07M	1.77M	1.53M	1.29M	1.01M	1.06M	1.51M	1.53M	1.51M
Other Non-Current Liabilities (Quarter)		0.04M	0.03M	0.01M	0.00M	0.00M	0.00M	0.00M	0.00M						6.16M	6.06M	18.80M	45.17M	43.91M	34.14M
Total Non-Current Liabilities (Quarter)		11.58M	83.62M	59.30M	54.42M	53.59M	51.73M	44.19M	40.43M		39.00M				30.05M	28.04M	24.89M	23.67M	25.33M	22.70M
Total Liabilities (Quarter)	11.15M	11.62M	83.65M	59.30M	54.42M	53.59M	51.73M	44.19M	40.43M	39.49M	39.00M	37.49M	35.93M	31.80M	36.21M	34.10M	43.69M	68.84M	69.24M	56.84M
Shareholder's Equity
Total Debt (Quarter)
Common Equity (Quarter)	123.60M	119.59M	90.90M	85.22M	81.50M	77.55M	71.94M	69.02M	71.26M	66.66M	62.02M	70.99M	66.88M	64.79M	77.01M	77.66M	47.11M	20.80M	44.55M	52.70M
Shareholder's Equity (Quarter)	123.60M	119.59M	90.90M	85.22M	81.50M	77.55M	71.94M	69.02M	71.26M	66.66M	62.02M	70.99M	66.88M	64.79M	77.01M	77.66M	47.11M	22.04M	43.35M	53.88M
Liabilities and Shareholders Equity (Quarter)	134.75M	131.21M	174.54M	144.52M	135.92M	131.15M	123.66M	113.20M	111.69M	106.15M	101.02M	108.48M	102.80M	96.59M	113.22M	111.75M	90.80M	89.64M	112.58M	109.53M
Treasury Shares (Quarter)							0.94M			0.76M	0.67M	0.50M	0.50M	0.50M	0.50M	0.33M	0.33M	0.33M	0.32M	0.25M
Retained Earnings (Quarter)	-3.05M	-308.11M	-337.10M	-344.18M	-3.36M	-357.02M	-3.57M	-367.74M	-2.61M	-380.08M	-3.07M	-391.40M	-397.16M	-400.19M	-403.46M	-2.68M	-4.10M	-4.29M	-467.00M	-471.81M
Preferred Shares (Quarter)

Research Tools

Lineage Cell Therapeutics Balance Sheet (2010-2026) | LCTX

Create an account

Sign In

Reset Password